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ABSTRACT 45 
Tropism of human cytomegalovirus (HCMV) is influenced by the envelope glycoprotein 46 
complexes gH/gL/gO and gH/gL/UL128-131.  During virion assembly, gO and the UL128-131 47 
proteins compete for binding to gH/gL in the ER.  This assembly process clearly differs among 48 
strains since Merlin (ME) virions contain abundant gH/gL/UL128-131 and little gH/gL/gO, 49 
whereas TR contains much higher levels of total gH/gL, mostly in the form of gH/gL/gO, but 50 
much less gH/gL/UL128-131 than ME.  Remaining questions include 1) what are the 51 
mechanisms behind these assembly differences, and 2) do differences reflect in vitro culture 52 
adaptations or natural genetic variations?  Since the UL74(gO) ORF differs by 25% of amino 53 
acids between TR and ME, we analyzed recombinant viruses in which the UL74(gO) ORF was 54 
swapped. TR virions were >40-fold more infectious than ME. Transcriptional repression of 55 
UL128-131 enhanced infectivity of ME to the level of TR, despite still far lower levels of 56 
gH/gL/gO.  Swapping the UL74(gO) ORF had no effect on either TR or ME.  A quantitative 57 
immunoprecipitation approach revealed that gH/gL expression was within 4-fold between TR 58 
and ME, but gO expression was 20-fold less by ME, and suggested differences in mRNA 59 
transcription, translation or rapid ER-associated degradation of gO.  Trans-complementation of 60 
gO expression during ME replication gave 6-fold enhancement of infectivity beyond the 40-fold 61 
effect of UL128-131 repression alone.  Overall, strain variations in assembly of gH/gL 62 
complexes result from differences in expression of gO and UL128-131, and selective 63 
advantages for reduced UL128-131 expression during fibroblast propagation are much stronger 64 
than for higher gO expression. 65 
IMPORTANCE 66 
Specific genetic differences between independently isolated HCMV strains may result from 67 
purifying selection on de novo mutations arising during propagation in culture, or random 68 
sampling among the diversity of genotypes present in clinical specimens.  Results presented  69 
indicate that while reduced UL128-131 expression may confer a powerful selective advantage 70 
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during cell-free propagation of HCMV in fibroblast cultures, selective pressures for increased gO 71 
expression are much weaker.  Thus, variation in gO expression among independent strains may 72 
represent natural genotype variability present in vivo. This may have important implications for 73 
virus-host interactions such as immune recognition, and underscores the value of studying 74 
molecular mechanisms of replication using multiple HCMV strains.   75 
INTRODUCTION 76 
 Human cytomegalovirus (HCMV) is widely spread throughout the world, found in 77 
approximately 60% of adults in developed countries and 100% in developing countries 78 
(reviewed in (1–3) (4)).  Immunocompromised individuals such as those infected with HIV 79 
patients, or transplant recipients under antirejection treatments can suffer HCMV related 80 
pathologies including gastroenteritis, encephalitis, retinitis, and vasculopathies, which can 81 
accelerate allograft rejection.  HCMV infection can also be acquired in utero and this is a 82 
significant cause of congenital neurological impairments and sensorineural hearing loss.  The 83 
transmission of HCMV is mainly through body liquid, such as urine and saliva (5).  Once 84 
infection is established, HCMV can spread throughout the body, infecting many of the major 85 
somatic cell types including, fibroblasts smooth muscle cells, epithelial and endothelial cells, 86 
neurons, and leukocytes such as monocytes-macrophages, and dendritic cells (6–9).   HCMV 87 
does not replicate efficiently in transformed cells (10, 11), thus most studies of the mechanisms 88 
governing HCMV tropism have involved dermal fibroblasts, and retinal pigment epithelial cells 89 
and umbilical cord endothelial cells, all of which can be easily cultured as normal, non-90 
transformed cells.   91 
 Much focus has been on the gH/gL complexes, which as for other herpesviruses, likely 92 
engage cell receptors and promote infection by contributing to the gB-mediated membrane 93 
fusion event or through activating cell signaling pathways (reviewed in (12, 13) (14)).  During 94 
virus assembly, the HCMV UL128-131 proteins and gO compete for binding to gH/gL to form 95 
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the pentameric complex gH/gL/UL128-131, or the trimeric complex gH/gL/gO.   Structural 96 
studies involving purified soluble complexes showed that gO and UL128 can each make a 97 
disulfide bond with cystine 144 of gL, and this was suggested to be the basis of the competitive 98 
assembly of the complexes (15).  However, Stegmann 2017 demonstrated that a mutant gO 99 
lacking the cysteine implicated in the disulfide bond with gL formed an intact, and functional 100 
gH/gL/gO (16).  This suggests that gO can engage in extensive non-covalent interactions with 101 
gH/gL.  The gH/gL/UL128-131 complex is dispensable for infection of cultured fibroblasts and 102 
neuronal cells, but required for infection of epithelial endothelial cells and monocyte-103 
macrophages  (17) (18) (19) (20) (21).  In contrast, gH/gL/gO is critical for infection of all cell 104 
types (22) (23) (24) (25).  Both complexes likely interact with cell receptors.   gH/gL/gO can bind 105 
platelet-derived growth factor receptor-alpha (PDGFR106 
interaction is critical for infection of fibroblasts (26–28).  Epithelial and endothelial cells do not 107 
express PDGFR, but blocking of gH/gL/gO either with neutralizing antibodies or with soluble 108 
PDGFR can inhibit infection of these cells, suggesting the existence of other gH/gL/gO 109 
receptors (26, 27).  Receptors for gH/gL/UL128-131 might include epidermal growth factor 110 
receptor (EGFR; also known as ErbB1), and 1 or 3 integrins, and these interactions may 111 
induce signaling cascades, critical for infection of selected cell types such as epithelial and 112 
endothelial cells and monocyte-macrophages (26, 29).  113 
 We recently reported that the amounts of gH/gL/gO, and gH/gL/UL128-131 in the virion 114 
envelope can differ dramatically among commonly studied strains of HCMV, and that this can 115 
affect the infectivity of the virions (25, 30).  The salient results of these studies were; 1) ME 116 
virions contained gH/gL mostly in the form of gH/gL/UL128-131, whereas TR and TB virions had 117 
mostly gH/gL/gO, 2) in terms of “total gH/gL”, the amount of gH/gL/gO in TR and TB virions was 118 
more than the gH/gL/UL128-131 in ME virions, 3) the infectivity of all three strains on both 119 
fibroblasts and epithelial cells correlated with the amount of gH/gL/gO, and 4) when the 120 
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expression of UL128-131 was suppressed in ME, virions contained dramatically less 121 
gH/gL/UL128-131, but only slightly more gH/gL/gO.  This latter point was especially curious 122 
since the model that gO and the UL128-131 proteins compete for binding to gH/gL would predict 123 
that the fraction of gH/gL normally bound by UL128-131 would, in their absence, be instead 124 
bound by gO.  This discrepancy could be explained by differences in the stoichiometric 125 
expression of gH/gL, gO, and UL128-131 between strains.  An alternative hypothesis was 126 
suggested by the fact that there are at least eight alleles of the UL74 gene that encodes gO 127 
(31). Isoforms of gO can vary between 10-30% of amino acids, and this could affect competition 128 
with UL128-131 for binding to gH/gL.  Both of these non-mutually exclusive hypotheses were 129 
addressed in the experiments reported here.  130 
RESULTS 131 
 Strains of HCMV display different patterns of glycoprotein expression and 132 
trafficking to virion assembly compartments.   The dramatic differences in the composition 133 
of gH/gL complexes in TR and ME virions described in Zhou 2013/2015 (25, 30) suggested 134 
corresponding differences in glycoprotein expression, and/or trafficking of glycoproteins to virion 135 
assembly compartments (AC).  To address these possibilities, cells were infected for 2 days 136 
(Fig 1A) or 5 days (Fig 1B) with TR or ME, and steady state amounts of viral proteins were 137 
compared by immunoblot.  At 2 dpi, immediate-early (IE)-1/2 levels were similar for both TR and 138 
ME, consistent with an equal multiplicity of infection.  At 5 dpi, the levels of the virion structural 139 
proteins MCP, gB, gH, and gL were also very similar between the two strains.  In contrast, ME 140 
infected cells contained dramatically more of the UL128-131 proteins than TR.  The UL148 141 
protein was also included in these analyses because it was recently described as an ER 142 
chaperone protein that influences the ratio of gH/gL complexes (32).  In TR-infected cells, an 143 
anti-UL148 antibody detected a prominent 35 kDa protein species, consistent with the previous 144 
description of the UL148 protein (32).  This 35-kDa species was not detected in ME-infected 145 
 o
n
 M
ay 15, 2018 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
cells.  Instead, ME-infected cells contained two species that were less abundant, and of faster 146 
and slower electrophoretic motilities than the single UL148 species detected in TR-infected 147 
cells.  The basis of the apparent size difference was not characterized, but could reflect 148 
differences in translational start/stop codon usage, splicing of the UL148 mRNA, or 149 
posttranslational modifications of the UL148 protein between strains.  Overall, the pattern of 150 
expression of the UL128-131, and UL148 proteins correlated well with the previously described 151 
pentamer-rich nature of ME virions and the trimer-rich nature of TR virions (25, 30).  Note that 152 
the expression of gO was not addressed in these analyses because the gO amino acid 153 
sequence differences between strains affects antibody recognition and precluded direct 154 
comparison (30).    155 
 Trafficking of gH/gL from the ER to TGN-derived assembly compartments was assessed 156 
by treating the 5 dpi infected-cell extracts with either endoglycosidase H (endo H) or PNGaseF, 157 
and then analyzing gH and gL by immunoblot (Fig 2).  The majority of gH and gL in TR-infected 158 
cells was endo H resistant, consistent with efficient transport from the ER to trans-Golgi-derived 159 
ACs.  In contrast, most of the gH and gL in ME-infected cells was sensitive to endo H digestion.  160 
In HFFFtet cells, which repress transcription from the UL128-131 locus (30) (33), there was 161 
even less endo H resistant gH and gL.  This suggested that the bulk of gH/gL trafficked to ACs 162 
in ME-infected nHDF, which allow UL128-131 expression, represented gH/gL/UL128-131 and is 163 
consistent with the previous observations that, 1) the bulk of gH/gL in the ME virion is pentamer, 164 
and 2) the loss of gH/gL in the form of pentamer in ME-T virions due to the repression of the 165 
UL128-131 proteins is apparently not fully compensated by the formation of complexes with gO 166 
(25, 30).  167 
 Differences in the amino acid sequence of gO between TR and ME do not affect 168 
the infectivity of cell free virus.  The predicted amino acid sequence of gO differs by 25% 169 
between TR and ME.  This sequence divergence precluded direct comparison of gO expression 170 
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levels because antibodies do not cross-react (30).  Furthermore, these sequence differences 171 
could potentially affect the ability of the distinct gO isoforms to compete with the UL128-131 172 
proteins for binding to gH/gL (thus influencing the amounts of gH/gL complexes in the mature 173 
virion envelope), or the function(s) of gO during entry, such as binding PDGFR or other 174 
receptors.  To address these possibilities, BAC recombineering methods were used to replace 175 
the gO ORF (UL74) of TR with the analogous sequences from ME, and visa versa to generate 176 
recombinant viruses denoted TRMEgO and METRgO.   177 
 Zhou 2015 demonstrated a positive correlation between the infectivity of HCMV virions 178 
and the amounts of gH/gL/gO in the virion envelope (25).  To assess the effects of gO 179 
sequences on infectivity, cell free virus stocks of parental wild type and heterologous gO 180 
recombinants were analyzed by qPCR to determine the number of virions, and infectivity was 181 
determined by plaque assay.  No difference in particles/PFU was observed between TR and the 182 
corresponding recombinant, TR_MEgO (Fig 3A), or between ME and the corresponding 183 
recombinant ME_TRgO (Fig 3B).  When the ME-based HCMV were grown in HFFFtet cells, 184 
which repress UL128-131 expression, the resultant virions, ME-T and ME-TTRgO, were 185 
dramatically more infectious, as shown before (25) (33), but consistently there were no 186 
differences due to the isoform of gO expressed (Fig. 3B).  In parallel analyses, the amounts of 187 
gH/gL complexes were analyzed by non-reducing immunoblot probing for gL to detect intact, 188 
disulfide linked gH/gL/gO, and disulfide-linked gH/gL/UL128 (note that UL130 and UL131 are 189 
not disulfide-linked to the intact pentamer complex and are thus separated by SDS-PAGE) (Fig 190 
4).  Consistent with our previous reports (25, 30), TR virions contained much greater amounts 191 
of total gH/gL, mostly in the form of gH/gL/gO, whereas ME virions contained less gH/gL, mostly 192 
as gH/gL/UL128-131. Repression of the UL128-131 proteins (ME-T) drastically reduced the 193 
amount of gH/gL/UL128-131, and increased the amount of gH/gL/gO.  However, note that the 194 
amount of gH/gL/gO in ME-T virions was still less than the gH/gL/UL128-131 in ME virions, 195 
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indicating that the repression of UL128-131 was not fully compensated by gO.  In no case did 196 
expression of the heterologous gO isoform detectably influence the amounts of gH/gL 197 
complexes in HCMV virions. Together these results suggest that the amino acid sequence 198 
differences between TR and ME gO do not influence gH/gL complex assembly, or the function 199 
of gO in entry into fibroblasts.    200 
 ME expresses less gO during replication than TR.  The heterologous gO 201 
recombinants allowed comparison of gO expression level between TR and ME.  In the first 202 
analyses cells infected with parental or the heterologous gO recombinants were analyzed by 203 
reducing immunoblot using TR and ME specific anti-gO antibodies (30) (Fig 5).  TR-specific gO 204 
antibodies detected two bands in TR-infected cells, a prominent species migrating just above 205 
the 100kDa marker, and a minor, more diffuse species migrating at approximately 130-140kDa. 206 
The ME-specific antibodies detected similarly migrating bands in TR_MEgO infected cells, 207 
however their relative abundance appeared more equal.  No similar bands were detected in 208 
cells infected with ME or ME_TRgO analyzed with either gO antiserum.  The failure to detect 209 
either isoform of gO in cells infected with ME-based HCMV suggested that protein expression 210 
from the UL74 locus of ME was lower than in TR.   211 
 To directly compare differences in glycoprotein expression between TR and ME, infected 212 
cells were labeled with [35]S-methionine/cysteine for 15 min, then analyzed by 213 
immunoprecipitation with anti-peptide antibodies specific for gH, gL, or gO, followed by SDS-214 
PAGE and band density analysis (Fig 6, Tables 1 and 2).  Two approaches were taken to allow 215 
for direct quantitative comparisons of labeled-proteins between extracts.  First, cell extracts 216 
were denatured and reduced with SDS/DDT prior to immunoprecipitation to allow maximum 217 
epitope access by the anti-peptide antibodies.  Second, for each analysis, multiple 218 
immunoprecipitation reactions were performed in parallel with increasing amounts of protein 219 
extract input to insure that antibodies were not limiting.   In these experiments, expression of gH 220 
was nearly identical between TR and ME, gL expression was approximately 4-fold higher for TR 221 
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than for ME, but gO expression was strikingly 27-fold higher for TR than for ME (Fig. 6A, Table 222 
1).  To address the possibility that the MEgO-specific antibodies were simply less efficient at 223 
capturing MEgO from ME extracts, similar experiments were performed with the TR-ME 224 
heterologous gO recombinants (Fig 6B, Table 2).  Again, gH and gL were similar between 225 
TR_MEgO and ME_TRgO, but gO levels were approximately 20-fold lower higher for the TR-226 
based virus.  To address the hypothesis that differences in gO expression between TR and ME 227 
reflect differences in protein turnover, the [35]S-methionine/cysteine label was chased for up to 228 
6 hours (Fig 7).  The pattern of gH detection over the chase time was very similar in both TR 229 
and ME samples.  In both cases, labeled gH dropped to 60% after 3 hours and to 30-40% after 230 
6 hours.  The pattern of gO detection for both TR and ME was comparable to that of gH.  231 
Together, these results confirmed that ME-infected cells express less gO than TR-infected cells, 232 
and suggested differences in early steps of expression such as mRNA transcription, translation 233 
or rapid ER-associated degradation, which can degrade proteins in the timescale of minutes 234 
(34). 235 
  Overexpression of gO during ME replication increased gH/gL/gO assembly and 236 
virus infectivity.  To directly test the hypothesis that the low abundance of gH/gL/gO in ME 237 
virions was due not simply to competition from the UL128-131 proteins, but also from low gO 238 
expression, Ad vectors were used to increase gO levels during ME replication.  Ad vectors 239 
expressing GFP were used to control for potential effects of the Ad vectors themselves. 240 
Consistent with the above analyses, gO levels were below the limits of immunoblot detection in 241 
ME-infected nHDF or HFFF-tet cells, but gO was readily detected in cells superinfected with 242 
AdMEgO (Fig 8A).  The overall expression of gL in ME infected cells was reduced by the 243 
presence of either Ad vector (Fig 8A).  In the case of the control AdGFP, the lower intracellular 244 
gL correlated with reduced gH/gL/gO complexes in virions from HFFFtet cells (ME-T) (Fig 8B), 245 
and this in turn correlated with reduced infectivity (i.e., increased particle PFU ratio) (Fig 9).  The 246 
“Ad effect” on virion gH/gL levels and infectivity was less apparent in HFF cells (ME), perhaps 247 
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masked by the overall higher amounts of gH/gL and much lower infectivity of these virions (Fig 248 
8B, and Fig. 9).  Controlling for the “Ad effect”, AdMEgO expression in HFFFtet increased the 249 
amounts of gH/gL/gO in ME-T virions compared to the AdGFP, and this resulted in a 6-fold 250 
enhancement of infectivity, beyond the 40-fold enhanced infectivity resulting from repression of 251 
UL128-131 alone (Fig 8B, and Fig. 9).  By contrast, AdMEgO expression had little effect on the 252 
virions from HFF cells.  253 
DISCUSSION 254 
 Recent population genetic studies have demonstrated a greater degree of genetic 255 
diversity of HCMV in clinical specimens than had been previously appreciated (35, 36) (37).  256 
The cell type and propagation methods likely narrow the resultant genotypes by purifying 257 
selection (38, 39).  During propagation in cultured fibroblasts, inactivating mutations in the 258 
UL128-131 ORFs are rapidly selected in a BAC clone of ME, and this selective pressure can be 259 
relieved by transcriptional repression of the UL131 promoter, which reduces expression of the 260 
pentameric gH/gL/UL128-131 (33)   In contrast, the UL128-131 ORFs are more stable in 261 
BAC clones of strain TR, and TB (39, 40).  The UL128-131 ORF of TB contains a single 262 
nucleotide polymorphism relative to ME that reduces splicing of the mRNA encoding the UL128 263 
protein, which may help stabilize the UL128-131 ORFs through reduced expression of 264 
gH/gL/UL128-131 (40).  However, TR is identical to ME at this nucleotide position, and a 265 
recombinant ME in which the UL128-131 locus was replaced with the UL128-131 sequences 266 
from TR was as sensitive to selective inactivation of the locus as was wild type ME (40).  267 
Together, these observations suggest that factors beyond expression level of the UL128-131 268 
proteins can influence the selective pressures on the UL128-131 ORFs.  269 
 The results reported here demonstrated that TR and ME differ in stoichiometry of 270 
expression of gO and UL128-131, and this seems to be a major factor determining the 271 
abundance of gH/gL/gO and gH/gL/UL128-131 in the virion envelope, and the infectivity of cell 272 
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free virion.  Fibroblasts infected with TR or ME were found to be comparable in the steady state 273 
levels of gH/gL, but ME-infected cells contained more UL128-131 than TR infected cells.  In ME-274 
infected cells, most of the gH/gL was an ER-associated form, whereas TR-infected cells 275 
contained a large amount of Golgi-associated gH/gL.  This correlated well with the previous 276 
observations that TR contained more total gH/gL than ME virions (25, 30).  The amount of 277 
Golgi-associated gH/gL in ME–infected cells was reduced when expression of the UL128-131 278 
proteins was repressed, consistent with the observation that most of the gH/gL in ME virions 279 
was in the form of gH/gL/UL128-131 (25, 30).  Comparison of gO expression between strains 280 
was complicated because the amino acid sequence differences between genotypes affected 281 
antibody recognition (30).  To circumvent this caveat, recombinant HCMV were engineered in 282 
which the UL74(gO) ORF of TR were replaced with the homologous sequences of ME, and vice 283 
versa.  This approach allowed the analysis of expression of both gO isoforms in both genetic 284 
backgrounds eliminating the possibility that the results were due to differences in antibody-285 
antigen affinities.  Immunoblot and radiolabeling experiments clearly demonstrated that ME-286 
infected cells contained less gO than TR-infected cells.  Overexpression of gO during ME 287 
replication had no effect on levels of gH/gL/gO, or infectivity of the virions unless UL128-131 288 
proteins were also transcriptionally repressed, and even then gH/gL/gO levels and infectivity 289 
were only modestly enhanced. Together these results underscore the competition between gO 290 
and UL128-131 for binding to gH/gL, and suggest other factors may influence the efficiency of 291 
gH/gL/gO assembly.   292 
 The molecular mechanisms underpinning the discrepancy between TR and ME in 293 
expression UL128-131, and gO remain unclear.  As mentioned above, Murrell 2013 described a 294 
SNP in the TB UL128-131 locus that affected mRNA splicing, in part explaining the lower 295 
expression of these proteins in TB (40).  However, this splicing effect does not explain the 296 
difference in UL128-131 expression between TR and ME since these strains are conserved at 297 
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this nucleotide position.  For gO, the radiolabeling analyses reported in  Figures 6 and 7, 298 
suggest the differences are due to early events in UL74(gO) expression such as transcription, 299 
mRNA processing/stability, translation, or rapid ER-associated degradation occurring in the 300 
timescale of minutes (34).  Attempts to analyze UL74(gO) mRNA levels between TR and ME by 301 
quantitative RT-PCR were complicated by the fact that HCMV genomes contain many 302 
overlapping RNAPII transcription units that vary between strains (41, 42).  It is interesting that 303 
ME-infected cells contained less UL148 than TR-infected cells.  UL148 was first described as an 304 
ER-resident chaperone protein that promotes the assembly of gH/gL/gO (32).  The mechanism 305 
may well involve interactions between UL148 and the cellular ER-associated degradation 306 
pathway (C. Nguyen, M. Siddiquey, H.Zhang, J. Kamil; presented at 42nd International 307 
Herpesvirus Workshop, 2017 Ghent Belgium).   308 
 The TR-ME heterologous gO recombinant viruses also allowed analysis of the effects of 309 
gO amino acid sequence differences on assembly of gH/gL complexes and the function of gO in 310 
entry.  No differences between TR and TRMEgO or between ME and METRgO  were 311 
observed in either the amounts of gH/gL complexes in virions, or cell free infectivity.  These 312 
results argue against the notion that the amino acid sequence differences between gO 313 
genotypes affect interactions with gH/gL or the binding of the fibroblast entry receptor, 314 
PDGFR.  Interestingly Kalser 2017 showed that replacing the endogenous gO of TB with the 315 
gO from Towne did not alter replication in cultured fibroblasts, but did enhance replication in 316 
epithelial cell cultures. (43).   Thus, it may be that gO sequence variation affects interactions 317 
with receptors other than PDGFR that mediated infection of epithelial cells.  318 
 Laib-Sampaio 2016 reported that mutational disruption of UL74(gO) expression in ME 319 
had little effect on replication unless the UL128-131 locus was also disrupted (24).  These 320 
authors suggested that spread of ME was mediated principally by gH/gL/UL128-131 in a cell-321 
associated manner, but when UL128-131 was inactivated, spread could also occur in a cell-free 322 
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manner mediated by gH/gL/gO.  This is in stark contrast to the dramatic phenotype reported for 323 
a gO null TR mutant (22).  Our finding that expression of gO by ME is low compared to TR may 324 
provide a partial explanation of these different gO null phenotypes.  325 
 It remains unclear whether the described difference in gO expression between TR and 326 
ME represents a bona fide variation that naturally exists between HCMV genotypes in vivo, or 327 
reflects differential selection on de novo mutations that occurred during the independent 328 
isolation of these strains from clinical specimens.  It seems clear that serial propagation of ME in 329 
cultured fibroblasts selects for de novo mutations that reduce or abolish the robust expression of 330 
the UL128-131 proteins (33, 39).  The selective pressure that fixes these mutations in the 331 
culture population may be explained by the specific infectivity analyses reported here (Figs. 3 332 
and 9) and in Zhou 2015 (25).  In both analyses the specific infectivity of TR was measured at 333 
approximately 100-200 particles/PFU, whereas ME was more 30-50-fold less infectious.  334 
Repression of the UL128-131 proteins enhanced the infectivity of ME (“ME-T”) to levels 335 
comparable to TR (approximately 100 particles/PFU).  While the infectivity of ME-T and TR 336 
virions was comparable, ME-T virions still contained far less gH/gL/gO than TR (Fig 4, and 337 
((25)).  Ad vector overexpression of gO enhanced infectivity of ME only 6-fold beyond the 338 
enhancement due to UL128-131 repression alone (Fig. 8 and 9).  Together, these observations 339 
would seem to suggest that in vitro selective pressures for reduced UL128-131 expression are 340 
much more pronounced than any for enhanced gO expression.  Thus, it is possible that the 341 
difference in gO expression between HCMV TR and ME derives not from selection on de novo 342 
mutations occurring during propagation in culture, but from nonselective, random sampling of 343 
the multitude of different genotypes that likely preexist in clinical specimens (35, 36) (37).  344 
Distinguishing these possibilities will require clear identification of the genomic sequences that 345 
determine gO expression level.      346 
MATERIALS AND METHODS 347 
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 Cell lines.  Primary neonatal human dermal fibroblasts (nHDF; Thermo Fisher 348 
Scientific), MRC-5 fibroblasts  (American Type Culture Collection; CCL-171), and HFFFtet cells 349 
(which express the tetracycline (Tet) repressor protein provided by Richard Stanton (Cardiff 350 
University, Cardiff, United Kingdom) (33) were grown in Dulbecco’s modified Eagle’s medium 351 
(DMEM: Thermo Fisher Scientific) supplemented with 6% heat-inactivated fetal bovine serum 352 
(FBS; Rocky Mountain Biologicals, Inc., Missoula, Montana, USA.) and 6% bovine growth 353 
serum (BGS; Rocky Mountain Biologicals, Inc., Missoula, Montana, USA.).   354 
 Human cytomegaloviruses. All HCMV were derived from bacterial artificial 355 
chromosome (BAC) clones.  The BAC clone of TR was provided by Jay Nelson (Oregon Health 356 
and Sciences University, Portland, OR, USA) (44). The BAC clone of Merlin (ME) (pAL1393), 357 
which carries tetracycline operator sequences in the transcriptional promoter of UL130 and 358 
UL131 was provided by Richard Stanton (Cardiff University, Cardiff, United Kingdom) (33).  359 
Infectious HCMV was recovered by electroporation of BAC DNA into MRC-5 fibroblasts as 360 
described by Wille et al. (22).  Cell-free HCMV stocks were produced by infecting HFF or 361 
HFFFtet at 2 plaque-forming unit (PFU) per cell.  At 8-10 days post infection (when cells were 362 
still visually intact), culture supernatants were harvested, and cellular contaminants were 363 
removed by centrifugation at 1,000 X g for 10min, and again at 6,000 X g for 10min.  Stocks 364 
were judged cell-free by the lack of calnexin, and actin in western blot analyses, and then stored 365 
at -80°C.  Freeze/thaw cycles were avoided.  Plaque-forming-units were determined by plating a 366 
series of 10-fold dilutions of each stock on replicate cultures of HFF for 2h at 37° C, and 367 
replacing the inoculum with a DMEM supplemented with 5% FBS, and 0.6% SeaPlaque 368 
agarose (to limit cell free spread).  Plaques were counted by light microscopy 3 weeks after 369 
infection. 370 
 Heterologous UL74(gO) recombinant HCMV.  A two step BAC recombineering 371 
process was performed as previously described (33).  In the first step, endogenous UL74 ORF 372 
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from start codon to stop codon of both TR and ME was replaced by a selectable marker.  373 
Briefly, overnight cultures of SW102 E. coli containing either the BAC clone of TR or ME were 374 
grown at 32° C until OD600=0.55.  Recombination genes were induced by incubating at 42° C 375 
for 15 mins.  Purified PCR product containing the selectable marker cassette, KanR/LacZ/RpsL 376 
flanked by sequences homologous to 80 base pairs upstream and downstream of the TR or ME 377 
UL74 ORF, was electroporated into the bacteria, cultures were recovered for 1h at 32° C, and 378 
then selected on media containing kanamycin (15ug/ml), IPTG (50uM), X-gal (20ug/ml) and 379 
chloramphenicol (12.5ug/ml).  First-step primer sequences were; TR: 5’-380 
CTTGGTGGACTATGCTTAACGCTCTCATTCTCATGGGAGCTTTTTGTATCGTATTACGACAT381 
TGCTGTTTCCAGAACTCCTGTGACGGAAGATCACTTCG-3’;   5`- 382 
CGACCAGAATCAGCAGTGAGTACACGCAGGCAAGCCAAACCACAAGGCAGACGGACGGT383 
GCGGGGTCTCCTCCTCTGTCCTGAGGTTCTTATGGCTCTTG-3`;  ME: 5`-384 
CCTGGTGGACTATGCTTAACGCTCTCATTCTGATGGGAGCTTTTTGTATCGTATTACGACAT385 
TGCTGCTTCCAGAACTCCTGTGACGGAAGATCACTTCG-3`; 5`- 386 
CGACCAGAATCAGCAGTGAGTACACGCAGGCAAACCAAACCACAAGGCAGACGGACGGT387 
GCGGGGTCTCCTCCTCTGTACTGAGGTTCTTATGGCTCTTG-3` 388 
 In the second step, the selectable marker cassette in the TR and ME first-step 389 
intermediate BACs was replaced with the UL74(gO) sequence from the heterologous strain.  390 
Briefly, E. coli were prepared for recombination as described for step one above, and 391 
electroporated with purified PCR products containing the UL74 ORF from TR or ME strain 392 
flanked by sequence homologous to 80 base pairs upstream and downstream of the opposite 393 
strain.  Transformed E. coli were selected for the removal of the KanR/LacZ/RpsL cassette by 394 
growth on media containing streptomycin (1.5mg/ml), IPTG (50uM), X-gal (20ug/ml) and 395 
chloramphenicol (12.5ug/ml).  Primers used to generate the second-step PCR produce were,  396 
TR UL74 into ME: 5`-397 
GCCTGGTGGACTATGCTTAACGCTCTCATTCTGATGGGAGCTTTTTGTATCGTATTACGACA398 
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TTGCTGCTTCCAGAACTTTACTGCAACCACCACCAAAG-3`, and 5`-399 
CGACCAGAATCAGCAGTGAGTACACGCAGGCAAACCAAACCACAAGGCAGACGGACGGT400 
GCGGGGTCTCCTCCTCTGTAATGGGGAGAAAAGGAGAGATG-3`.   ME UL74 into TR:  5`- 401 
GGCTTGGTGGACTATGCTTAACGCTCTCATTCTCATGGGAGCTTTTTGTATCGTATTACGAC402 
ATTGCTGTTTCCAGAACTTTACTGCGACCACCACCAAA-3`, and 5`- 403 
CAGAATCAGCAGTGAGTACACGCAGGCAAGCCAAACCACAAGGCAGACGGACGGTGCGG404 
GGTCTCCTCCTCTGTCATGGGGAAAAAAGAGATGATAATGG 405 
 The final heterologous UL74(gO) recombinants were verified by Sanger sequencing 406 
PCR products using the following primers;  TRMEgO: 5`-407 
GATGATTTTTACAAGGCACATTGTACATC-3`, and 5`-AACTAGGTCGTCTTGGAAGC-3`,    408 
METRgO: 5`-CTCACAATGATTTTTACAATGCG-3`, and 5`-AACTAGGTCGTCTTGGAAGC-3`.    409 
 Antibodies. Rabbit polyclonal anti-peptide antibodies specific for TBgO and MEgO were 410 
described previously (30).  Rabbit polyclonal antibodies specific for UL148 were described 411 
(32).  Rabbit polyclonal, anti-peptide antibodies against gH, gL, UL130 and UL131 were 412 
provided by David Johnson (Oregon Health and Sciences University, Portland, OR, USA) (45). 413 
Anti-UL128 monoclonal antibodies (mAb) 4B10 were provided by Tom Shenk (Princeton 414 
University, Princeton, NJ, USA) (46). mAbs directly against major capsid protein (MCP) 28-4 415 
and gB 27-156 were provided by Bill Britt (47, 48).  mAb (CH160) against CMV immediate early 416 
protein1 and immediate early protein2  (IE1/IE2) was purchased from Abcam (Cambridge, MA, 417 
USA).  418 
 Immunoblot. HCMV-infected cells or cell free virions were solubilized in 2% SDS/ 419 
20mM Tris-buffered saline (TBS) (pH 6.8).  Insoluble material was cleared by centrifugation at 420 
16,000 × g for 15 min and then extracts were boiled for 10 min.   For endoglycosidase H (endo 421 
H) or peptide N-glycosidase F (PNGase F) treatment assay, proteins were extracted in 1% 422 
Triton X-100 (TX100), 0.5% sodium deoxycholate (DOC) in 20 mM Tris (pH 6.8), 100 mM NaCl 423 
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(TBS-TX/DOC). Extracts were clarified by centrifugation 16,000 × g for 15 min and treated with 424 
with endo H or PNGase F according to manufacturer’s instructions (New England BioLabs).  For 425 
reducing blots, dithiothereitol (DTT) were added to extracts to a final concentration of 25 mM. 426 
After separation by SDS-PAGE, proteins were transferred to polyvinylidene difluoride (PVDF) 427 
membranes (Whatman) in a buffer containing 10 mM NaHCO3 , 3 mM Na2CO3 (pH 9.9) plus 428 
10% methanol.  Transferred proteins were probed with mAbs or rabbit polyclonal antibodies,  429 
anti-rabbit or anti-mouse secondary antibodies conjugated with horseradish peroxidase (Sigma-430 
Aldrich), and Pierce ECL-Western Blotting Substrate (ThermoFisher Scientific).  431 
Chemiluminescence was detected using a Bio-Rad ChemiDoc MP imaging system.   432 
 Radiolabeling proteins.  Cell cultures were incubated in labeling medium (met/cys-free 433 
DMEM + 2% dialyzed FBS) lacking methionine and cysteine) for 2 h at 37 °C, then [35S] 434 
methionine-cysteine was added to 1 mCi/ml (EasyTag Express 35S Protein Labeling Mix; 435 
Perkin Elmer).  For chase experiments, label medium was removed and cultures were washed 436 
twice in DMEM + 2% FBS supplemented with a 10-fold excess of nonradioactive methionine 437 
and cysteine, then incubated in this medium for the indicated time.   438 
 Immunoprecipitation.  Cell extracts were harvested in TBS-TX/DOC supplemented 439 
with 0.5% bovine serum albumin (BSA) and 1mM phenylmethylsulfonyl fluoride (PMSF), 440 
clarified by centrifugation at 16,000 × g for 15 min, adjusted to 2% SDS, 30 mM DTT and 441 
heated at 75 °C for 15 min.  The extracts were then diluted 35-fold with TBS-TX/DOC 442 
supplemented with 0.5% BSA, and 10 mM iodoacetamide, incubated on ice for 15 min and pre-443 
cleared with protein A-agarose beads (Invitrogen/ThermoFisher Scientific) for at 4 °C for 2 h.  444 
Immunoprecipition reactions were set up with specific antibodies and protein A-agarose beads 445 
and incubated overnight at 4°C.  Protein A-agarose beads were washed 3 times with TBS-446 
TX/DOC and proteins were eluted with 2% SDS, 30 mM DTT in TBS at RT for 15 min, followed 447 
by 75 °C for 10 min.  Eluted proteins were separated by SDS-PAGE and analyzed with a 448 
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Typhoon FLA-9500 imager (GE Healthcare Life Sciences).  Band densities were determined 449 
using ImageJ version 1.48 software.   450 
 Quantitative PCR.  Viral genomes were determined as described (25).  Briefly, Cell-451 
free HCMV stocks were treated with DNase I before extraction of viral genomic DNA (PureLink 452 
Viral RNA/DNA minikit; Life Techonologies/ThermoFisher Scientific). Primers specific for 453 
sequences within UL83 were used with the MyiQ real-time PCR detection system (Bio-Rad).  454 
 Superinfection of HCMV-infected cells with replication-defective adenovirus 455 
vectors.  Construction of Ad vectors expressing MEgO or GFP was described (30).   At 2 days 456 
post HCMV infection, cells were superinfected with 20 PFU/cell of AdMEgO or AdGFP.  6 days 457 
later, cell-free HCMV was collected from the supernatant culture by centrifugation, and cells 458 
were harvested for immunoblot.  459 
 460 
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FIGURE LEGENDS  470 
Figure 1.  Comparison of protein expression between TR and ME.  nHDF were infected with 471 
1 PFU/cell of TR or ME.  At day 2 (A) or day 5 (B) total cell extracts were separated by reducing 472 
SDS-PAGE and analyzed by immunoblot probing for immediate early (IE)-1/2, major capsid 473 
protein (MCP), gB, gH, gL, UL128, UL130, UL131, or UL148.  Arrowheads indicate the positions 474 
of the cleaved 100kDa and 55 kDa fragments of gB. 475 
 476 
Figure 2.  Analysis of ER-to-transGolgi compartment trafficking of glycoproteins in TR or 477 
ME infected cells.  Extracts of nHDF infected with TR or ME, or HFFFtet cells infected with ME 478 
were treated with endoglycosidase H (H), PNGaseF (F) or left untreated (U), and then 479 
separated by reducing SDS-PAGE and analyzed by immunoblot probing for gH or gL.  480 
Arrowheads indicate the position of the faster migrating, deglycosylated species. 481 
 482 
Figure 3.  Specific infectivity of parental and TR-ME heterologous gO recombinants.  483 
Extracellular virions of TR, TR_MEgO, ME, ME_TRgO, ME-T, or ME-T_TRgO were analyzed by 484 
quantitative PCR for viral genomes and PFU were determined by plaque assay on nHDF.  485 
Average particle-PFU ratios from at least 4 independent experiments are plotted. Error bars 486 
 o
n
 M
ay 15, 2018 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
 represent standard deviation. 487 
 488 
Figure 4.  Immunoblot analysis of gH/gL complexes in parental and TR-ME heterologous 489 
gO recombinants. Extracellular virion extracts of TR, TR_MEgO, ME, ME_TRgO, ME-T, or 490 
ME-T_TRgO were separated by reducing (A and B) or non-reducing (C) SDS-PAGE and 491 
analyzed by immunoblot probing for major capsid protein (A) or gL (B and C) 492 
 493 
Figure 5.  Immunoblot analysis of gO expression in cells infected with parental and TR-494 
ME heterologous gO recombinants.  nHDF were infected with 1 PFU/cell of TR, TR_MEgO, 495 
ME, or ME_TRgO.  At day 5, total cell extracts of infected cells were separated by reducing 496 
SDS-PAGE and analyzed by immunoblot probing for TRgO, MEgO, major capsid protein 497 
(MCP), or actin. 498 
 499 
Figure 6.  Quantitative comparison of glycoprotein expression in TR and ME infected 500 
cells.  nHDF were infected with 1 PFU/cell of TR or ME (A), or TR_MEgO or ME_TRgO (B).  At 501 
5 dpi, infected cells were metabolically labeled with [35]-S cysteine/methionine for 15 min and 502 
membrane proteins were extracted in 1% Triton X-100.  All samples were adjusted to 503 
2%SDS/30mM DTT, heated to 75° C for 10 min, cooled to room temperature and then diluted 504 
35-fold.   Parallel immunoprecipitations were performed in which equal amounts of anti-gH, gL, 505 
or gO (TR or ME specific) antibodies were reacted with 3-fold increasing amounts of protein 506 
extract as input, and precipitated proteins were analyzed by SDS-PAGE.   507 
 508 
Figure 7.  Analysis of glycoprotein turnover in TR and ME infected cells.  nHDF were 509 
infected with 1 PFU/cell of TR or ME.  At 5 dpi, infected cells were metabolically labeled with 510 
[35]-S cysteine/methionine for 15 minutes and then label was chased for 0, 10, 60, 180, or 360 511 
minutes.  Membrane proteins were extracted in 1% Triton X-100, adjusted to 2%SDS/30mM 512 
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 DTT, heated to 75° C for 10 min, cooled to room temperature and then diluted 35-fold.  513 
Immunoprecipitation was performed with anti-gH, gO (TR or ME specific) antibodies and 514 
precipitated proteins were analyzed by SDS-PAGE.  Band densities were determined relative to 515 
the 0 minute chase time. Results shown are representative of 4 independent experiments. 516 
 517 
Figure 8.  Ad vector overexpression of gO during ME replication.  nHDF or HFFF-tet cells 518 
were infected with ME for 2 days, then superinfected with Ad vectors expressing either GFP or 519 
MEgO for an additional 4 days. Extracts of infected cells (A), or extracellular virions (B) were 520 
separated by reducing (A, and B; top) or non-reducing (B; bottom) SDS-PAGE and analyzed by 521 
immunoblot probing for MEgO, actin, major capsid protein (MCP), or gL as indicated to the right. 522 
 523 
Figure 9.  Specific infectivity of ME virions produced under conditions of gO 524 
overexpression.  nHDF or HFFF-tet cells were infected with ME for 2 days, then superinfected 525 
with Ad vectors expressing either GFP or MEgO for an additional 4 days.  Extracellular virions 526 
from nHDF (ME) or HFFFtet (ME-T) were analyzed by quantitative PCR for viral genomes, and 527 
PFUs determined by plaque assay on nHDF.  Shown are average particle-PFU ratios of virions 528 
produced in 2 independent experiments, each analyzed in triplicate.   Error bars represent the 529 
standard deviation.  Asterisks (*) above fold differences indicate  P < 0.03  (Student’s unpaired 530 
T-test (2-tailed)). 531 
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Zhang et al., Figure 1
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Figure 1.  Comparison of protein expression between TR and ME.  nHDF were 
infected with 1 PFU/cell of TR or ME.  At day 2 (A) or day 5 (B) total cell extracts were 
separated by reducing SDS-PAGE and analyzed by immunoblot probing for immediate 
early (IE)-72, major capsid protein (MCP), gB, gH, gL, UL128, UL130, UL131, or 
UL148.  Arrowheads indicate the positions of the cleaved 100kDa and 55 kDa 
fragments of gB.   
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Figure 2.  Analysis of ER-to-transGolgi compartment trafficking of 
glycoproteins in TR or ME infected cells.  Extracts of nHDF infected with TR or 
ME, or HFFFtet cells infected with ME were treated with endoglycosidase H (H), 
PNGaseF (F) or left untreated (U), and then separated by reducing SDS-PAGE 
and analyzed by immunoblot probing for gH or gL.  Arrowheads indicate the 
position of the faster migrating, deglycosylated species.        
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Zhang et al., Figure 3
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Figure 3.  Specific infectivity of parental and TR-ME heterologous gO 
recombinants.  Extracellular virions of TR, TR_MEgO, ME, ME_TRgO, ME-T, or 
ME-T_TRgO were analyzed by quantitative PCR for viral genomes and PFU were 
determined by plaque assay on nHDF.  Average particle-PFU ratios from at least 4 
independent experiments are plotted. Error bars represent standard deviation.   
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Zhang et al., Figure 4
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Figure 4.  Immunoblot analysis of gH/gL complexes in parental and TR-ME heterologous 
gO recombinants. Extracellular virion extracts of TR, TR_MEgO, ME, ME_TRgO, ME-T, or 
ME-T_TRgO were separated by reducing (A and B) or non-reducing (C) SDS-PAGE and 
analyzed by immunoblot probing for major capsid protein (A) or gL (B and C). 
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Zhang et al., Figure 5
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Figure 5.  Immunoblot analysis of gO expression in cells infected with parental and TR-ME 
heterologous gO recombinants.  nHDF were infected with 1 PFU/cell of TR, TR_MEgO, ME, or 
ME_TRgO.  At day 5, total cell extracts of infected cells were separated by reducing SDS-PAGE 
and analyzed by immunoblot probing for TRgO, MEgO, major capsid protein (MCP), or actin.  
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Figure 6.  Quantitative comparison of glycoprotein expression in TR and ME infected 
cells.  nHDF were infected with 1 PFU/cell of TR or ME (A), or TR_MEgO or ME_TRgO (B).  
At 5 dpi, infected cells were metabolically labeled with [35]-S cysteine/methionine for 15 min 
and membrane proteins were extracted in 1% Triton X-100.  All samples were adjusted to 
2%SDS/30mM DTT, heated to 75° C for 10 min, cooled to room temperature and then diluted 
35-fold.   Parallel immunoprecipitations were performed in which equal amounts of anti-gH, 
gL, or gO (TR or ME specific) antibodies were reacted with 3-fold increasing amounts of 
protein extract as input, and precipitated proteins were analyzed by reducing SDS-PAGE.       
Zhang et al., Figure 6
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Figure 7.  Zhang et al
Figure 7.  Analysis of glycoprotein turnover in TR and ME infected cells.  nHDF 
were infected with 1 PFU/cell of TR or ME.  At 5 dpi, infected cells were metabolically 
labeled with [35]-S cysteine/methionine for 15 minutes and then label was chased for 0, 
10, 60, 180, or 360 minutes.  Membrane proteins were extracted in 1% Triton X-100, 
adjusted to 2%SDS/30mM DTT, heated to 75° C for 10 min, cooled to room temperature 
and then diluted 35-fold.  Immunoprecipitation was performed with anti-gH, gO (TR or ME 
specific) antibodies and precipitated proteins were analyzed by SDS-PAGE.  Band 
densities were determined relative to the 0 minute chase time.  Results shown are 
representative of 4 independent experiments.     
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Figure 8.  Ad vector overexpression of gO during ME replication.  nHDF or HFFF-tet cells were 
infected with ME for 2 days, then superinfected with Ad vectors expressing either GFP or MEgO for 
an additional 4 days. Extracts of infected cells (A), or extracellular virions (B) were separated by 
reducing (A, and B; top) or non-reducing (B; bottom) SDS-PAGE and analyzed by immunoblot 
probing for MEgO, actin, major capsid protein (MCP), or gL as indicated to the right.  
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Figure 9.  Specific infectivity of ME virions produced under conditions of gO overexpression.  
nHDF or HFFF-tet cells were infected with ME for 2 days, then superinfected with Ad vectors 
expressing either GFP or MEgO for an additional 4 days.  Extracellular virions from nHDF (ME) or 
HFFFtet (ME-T) were analyzed by quantitative PCR for viral genomes, and PFUs determined by 
plaque assay on nHDF.  Shown are average particle-PFU ratios of virions produced in 2 
independent experiments, each analyzed in triplicate.   Error bars represent the standard deviation.  
Asterisks (*) above fold differences indicate  P < 0.03  (Student’s unpaired T-test (2-tailed)).  
Zhang et al., Figure 9
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Table 1.  Quantitative comparison of glycoprotein expression in TR and ME 
infected cells. 
IP 
Antibodya 
Extractb 
(mL) 
 
Strain 
 
Foldf  
 
Mean Foldg 
  TR  ME   
   
Densityc 
Adjusted 
Densitye 
  
Density 
Adjusted 
Density 
  
anti-gH 0.04 n.d.d n.d.  n.d. n.d.   
 0.13 136.7 4.6  106.6 3.4 1.3  
 0.40 476.9 15.9  337.8 10.9 1.5  
 1.20 1200.7 40.0  872.9 28.2 1.4  
        1.4(+/-0.1) 
         
anti-gL 0.04 143.8 11.1  n.d. n.d. n.d.  
 0.13 679.1 52.2  127.2 9.8 5.3  
 0.40 1627.3 125.2  509.3 39.2 3.2  
 1.20 6071.3 467.0  1809.9 139.2 3.4  
        4.0 (+/-1.2) 
         
anti-gO 0.04 267.0 12.1  n.d. n.d. n.d.  
 0.13 1008.6 45.8  n.d. n.d. n.d.  
 0.40 3805.4 173.0  120.8 5.0 34.4  
 1.20 9251.8 420.5  478.9 20.0 21.1  
        27.2 (+/-9.4) 
a. 7uL of rabbit anti-peptide serum per immunoprecipitation reaction 
b. Preparation of radiolabeled cell extracts described in legend to Figure 6, and in 
materials and methods.   
c. Densities of bands shown in Figure 6A as determined using Image J v. 1.48 
d. Band density not detected. 
e. Density divided by the predicted number of methionine and cysteine residues: 
TRgH(30), MEgH(31), TRgL(13), MEgL(13), TRgO(22), MEgO(24) 
f. Adjusted density TR divided by adjusted density ME. 
g. Average fold difference between TR and ME +/- standard deviation. 
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Table 2.  Quantitative comparison of glycoprotein expression in TR_MEgO and 
ME_TRgO infected cells. 
IP 
Antibodya 
Extractb 
(mL) 
 
Strain 
 
Foldf  
 
Mean Foldg 
  TR_MEgO  ME_TRgO   
   
Densityc 
Adjusted 
Densitye 
  
Density 
Adjusted 
Density 
  
anti-gH 0.04 68.4 2.3  29.5 1.0 2.4  
 0.13 181.6 6.1  163.1 5.3 1.1  
 0.40 539.5 18.0  410.6 13.2 1.4  
 1.20 1697.7 56.6  1064.0 34.3 1.6  
        1.6(+/-0.5) 
         
anti-gL 0.04 n.d.d n.d.  n.d. n.d. n.d.  
 0.13 196.6 15.1  153.8 11.8 1.3  
 0.40 645.0 49.6  508.3 39.1 1.3  
 1.20 2547.5 196.0  1269.6 97.7 2.0  
        1.5 (+/-0.4) 
         
anti-gO 0.04 187.8 7.8  n.d. n.d. n.d.  
 0.13 945.8 39.4  n.d. n.d. n.d.  
 0.40 2580.3 107.5  127.8 5.8 18.5  
 1.20 10502.7 437.6  460.1 20.9 20.9  
        19.7 (+/-1.7) 
a. 7uL of rabbit anti-peptide serum per immunoprecipitation reaction 
b. Preparation of radiolabeled cell extracts described in legend to Figure 6, and in 
materials and methods.   
c. Densities of bands shown in Figure 6B as determined using Image J v. 1.48 
d. Band density not detected. 
e. Density divided by the predicted number of methionine and cysteine residues: 
TRgH(30), MEgH(31), TRgL(13), MEgL(13), TRgO(22), MEgO(24) 
f. Adjusted density TR_MEgO divided by adjusted density ME_TRgO. 
g. Average fold difference between TR_MEgO and ME_TRgO +/- standard deviation. 
 o
n
 M
ay 15, 2018 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
